Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: Associations with disease activity, treatment response, and prediction of a clinical relapse

    Access Status
    Fulltext not available
    Authors
    Gerasimidis, K.
    Nikolaou, C.
    Edwards, Christine
    McGrogan, P.
    Date
    2011
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Gerasimidis, K. and Nikolaou, C. and Edwards, C. and McGrogan, P. 2011. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: Associations with disease activity, treatment response, and prediction of a clinical relapse. Journal of Clinical Gastroenterology. 45 (3): pp. 234-239.
    Source Title
    Journal of Clinical Gastroenterology
    DOI
    10.1097/MCG.0b013e3181f39af5
    ISSN
    0192-0790
    URI
    http://hdl.handle.net/20.500.11937/39661
    Collection
    • Curtin Research Publications
    Abstract

    Background: Exclusive enteral nutrition (EEN) induces clinical remission in pediatric Crohn's disease (CD). GOALS: This study explored changes in fecal calprotectin concentration during treatment with EEN. STUDY: Fecal calprotectin was measured in 4 serial stool samples from CD children during EEN. The Pediatric Crohn's Disease Activity Index (PCDAI) and systemic markers of disease activity were measured at the beginning and end of treatment. Results: Fifteen CD children (7 girls; 11.6±2.3 y) participated. PCDAI decreased in 14 children and 7 children achieved clinical remission (PCDAI =10). Fecal calprotectin concentration decreased (30 d, P=0.014; 60 d, P<0.0001) only in those children who entered clinical remission (PCDAI =10). In the whole group mean calprotectin concentration at baseline (2158±642 mg/kg) was reduced by 975 mg/kg (95% confidence interval -1783; -167) after 30 days and 1700 mg/kg (95% confidence interval -2508; -892) on EEN completion. Only one child reached normal levels by the end of EEN. Decrease of pretreatment calprotectin levels by more than 18% after 30 days on EEN predicted clinical response at the end of EEN. Calprotectin levels at the end of EEN treatment did not predict the length of time lapsed to a future relapse. Conclusions: In this pilot study calprotectin decreased in patients who achieved clinical remission and may be useful to predict response to treatment. Copyright © 2011 by Lippincott Williams & Wilkins.

    Related items

    Showing items related by title, author, creator and subject.

    • Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition
      Quince, C.; Ijaz, U.; Loman, N.; Eren, A.; Saulnier, D.; Russell, J.; Haig, S.; Calus, S.; Quick, J.; Barclay, A.; Bertz, M.; Blaut, M.; Hansen, R.; Mcgrogan, P.; Russell, R.; Edwards, Christine; Gerasimidis, K. (2015)
      © 2015 by the American College of Gastroenterology. OBJECTIVES:Exploring associations between the gut microbiota and colonic inflammation and assessing sequential changes during exclusive enteral nutrition (EEN) may offer ...
    • Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition
      Gerasimidis, K.; Bertz, M.; Hanske, L.; Junick, J.; Biskou, O.; Aguilera, M.; Garrick, V.; Russell, R.; Blaut, M.; McGrogan, P.; Edwards, Christine (2014)
      Background: The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial ...
    • Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis
      Biskou, O.; Gardner-Medwin, J.; Mackinder, M.; Bertz, M.; Clark, C.; Svolos, V.; Russell, R.; Edwards, Christine; McGrogan, P.; Gerasimidis, K. (2016)
      © 2016 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,ABSTRACT: This study aimed to provide evidence on whether children at risk of ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.